Drug intelligence / Profile preview

gamma delta tocotrienols

Development stage
Unknown
Lead developer
National Cancer Institute
Modality
Small Molecules
Administration
Oral
01

Overview

Gamma delta tocotrienols is a tocotrienol-enriched fraction (TRF) derived from palm oil, primarily composed of the gamma and delta isomers of tocotrienol, which are members of the vitamin E family. It is being investigated as a nutraceutical supplement for the treatment of hypercholesterolemia, particularly as an adjunct to statin therapy. The primary mechanism of action involves the post-transcriptional suppression and accelerated degradation of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, the rate-limiting enzyme in the mevalonate pathway for cholesterol biosynthesis. By reducing the cellular pool of HMG-CoA reductase, gamma delta tocotrienols inhibit hepatic cholesterol production and lower serum LDL cholesterol levels. The University of California, Los Angeles (UCLA) has conducted Phase 3 clinical trials to evaluate the lipid-lowering effects of this specific tocotrienol fraction in hypercholesterolemic subjects.

Brand names
Palmvitee
Other names
tocotrienol-enriched fraction of palm oilTRFgamma-tocotrienoldelta-tocotrienol
02

Targets

STAT3 (Signal Transducer and Activator of Transcription 3)HMGCR (3-hydroxy-3-methylglutaryl-coenzyme A reductase)Sterol regulatory element-binding protein processing machinery (SREBP processing machinery)

Beyond the preview

Go deeper on gamma delta tocotrienols.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on gamma delta tocotrienols.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call